Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Sue Yom
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
222 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tom Baker Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca-Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada
- Windsor Regional Cancer Centre
Windsor, Ontario, Canada
- Chum - Hopital Notre-Dame
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- Mcgill University Department of Oncology
Montreal, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Saint Lukes Hospital
Dublin, Co Dublin, Ireland
- King Faisal Specialist Hospital and Research Centre
Riyadh, Saudi Arabia
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
Cameron Park, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Marin General Hospital
Greenbrae, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Memorial Medical Center
Modesto, California, United States
- Kaiser Permanente Oakland-Broadway
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California, United States
- Rohnert Park Cancer Center
Rohnert Park, California, United States
- Sutter Cancer Centers Radiation Oncology Services-Roseville
Roseville, California, United States
- the Permanente Medical Group-Roseville Radiation Oncology
Roseville, California, United States
- South Sacramento Cancer Center
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Naval Medical Center -San Diego
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Stanford Cancer Center South Bay
San Jose, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2014
- Primary completion
- 10 Jun 2019
- Completion
- 4 Sept 2025
- Last update posted
- 22 May 2026
- Registered enrollment
- 316
- Registry id
- NCT02254278
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.